Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rafael Holdings, Inc.

1.78
+0.08835.22%
Volume:46.08K
Turnover:80.56K
Market Cap:62.40M
PE:-0.84
High:1.88
Open:1.71
Low:1.69
Close:1.69
Loading ...

Rafael Holdings Inc. Files Initial Statement of Beneficial Ownership; N. Scott Fine Named as Director

Reuters
·
23 Jul

Rafael Holdings Inc. Announces Continuation of Phase 3 TransportNPC Study for Trappsol® Cyclo™ Following Positive Interim Analysis

Reuters
·
18 Jun

Cyclo Therapeutics' Phase 3 NPC1 Study Advances with Positive Interim Data Review

Reuters
·
18 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Vaxart, DoubleVerify, Cracker Barrel

Reuters
·
12 Jun

BRIEF-Rafael Holdings Q3 Net Income USD -4.051 Million

Reuters
·
11 Jun

Rafael Holdings Reports Q3 FY2025 Net Loss of $4.8M, EPS Improves to $0.19 from $1.36 Year-Over-Year

Reuters
·
11 Jun

Press Release: Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results

Dow Jones
·
11 Jun

Exec Chairman, CEO & President Howard S. Jonas Acquires Common Shares of Rafael Holdings Inc

Reuters
·
10 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Copper miners, Chip Stocks, EchoStar

Reuters
·
10 Jun

Rafael Closes $25 Million Rights Offering

MT Newswires Live
·
05 Jun

Press Release: Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering

Dow Jones
·
05 Jun

Protara Therapeutics Names William Conkling as Chief Commercial Officer

MT Newswires Live
·
03 Jun

Press Release: Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol(R) Cyclo(TM)

Dow Jones
·
21 May

Rafael Holdings Inc. Announces New Standby Purchase Agreement with Howard S. Jonas

Reuters
·
07 May

Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

GlobeNewswire
·
30 Apr

Rafael Holdings CEO Conkling Steps Down; Replaced by Former CEO Jonas

Dow Jones
·
25 Apr

Press Release: Rafael Holdings Strengthens its Focus on the Development of Trappsol(R) Cyclo(TM) and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role

Dow Jones
·
25 Apr

Singapore Red Cross pledges S$150,000 to support Myanmar, Thailand quake relief

CNA
·
29 Mar

Rafael Closes Merger With Cyclo Therapeutics

MT Newswires Live
·
26 Mar

Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals

GlobeNewswire
·
26 Mar